|
David R. Snydman, MD, FACP, FIDSA
Personal Faculty Page
Titles
Chief, Division of Geographic Medicine and Infectious Diseases and Hospital Epidemiologist, Tufts Medical Center
Professor of Medicine and Pathology, Tufts University School of Medicine
Education Background
BA, Williams College, 1968
MD, University of Pennsylvania School of Medicine, 1972
Internship in Medicine, New England Medical Center 1972-1973
Residency, New England Medical Center 1973-1974
United States Public Health Service, Epidemic Intelligence Service, Centers for Disease Control 1974-1976
Infectious Disease Fellowship, New England Medical Center 1976-1979
Research Interests
Transplantation infectious diseases, epidemiologic aspects of infectious diseases, cytomegalovirus infections, hospital infections, antimicrobial resistance, anaerobic resistance and probiotics.
Clinical Interests
General infectious diseases, cytomegaloviruses and transplantation infectious diseases.
Honors and Awards
| 2011 |
The Ninth Harold C. Neu, MD Visiting Professor at Columbia Presbyterian Hospital and Columbia University School of Medicine |
| 2011 |
Raymond A. Koff, MD Honarary Lecture at MetroWest Medical Center |
| 2009 |
Distinguished Faculty Lecture at Tufts University School of Medicine Alumni Meeting |
|
2009-2011 |
Castle Connolly and Boston Magazine Best Doctors |
| 2007 |
Fellowship, American College of Physicians |
| 2004 |
Co-recipient of Emanuel Wolinsky Award given by IDSA/CID as an author for the Best Article Published in Clinical Infectious Diseases in 2003 |
| 2004 |
Distinguished Faculty Award, Tufts University School of Medicine |
| 2003 |
Ken Kaplan, MD Clinician award from the Massachusetts Chapter of the Infectious Diseases Society of America |
| 2002 |
Pfizer Visiting Scholar to Emory University School of Medicine |
| 1998-2012 |
Americas Best Doctor’s Selection |
| 1998 |
The Milton O. and Natalie V. Zucker Faculty Research Award of Tufts University School of Medicine and Sackler School of Graduate Medical Sciences |
| 1994 |
Citation from Massachusetts Biologic Laboratories for Development of Cytomegalovirus Immune Globulin |
| 1990 |
Fellowship Teaching Award (created in 1990 by ID Fellows) |
| 1989 |
Elected to Fellowship of Infectious Disease Society of America |
| 1979-1982 |
Teaching and Research Scholar of the American College of Physicians |
| 1978-1979 |
Bristol Fellowship of the Infectious Disease Society of America |
| 1972 |
Dr. A.O.J. Kelly Prize |
Recent Publications
Kotton CN, Kumar D, Caliendo AM, Asberg A, Chou S, Snydman DR, Allen U, Humar A; on behalf of The Transplantation Society International CMV Consensus Group. International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ Tranplantation. Transplantation, 2010; 89:779-795. PMID: 20224515
Snydman DR , Kistler KD, Ulsh P, Morris J. Cytomegalovirus prevention and long-term recipient and graft survival in pediatric heart transplant recipients. Transplantation 2010;90:1432-1438. PMID: 21076378
Chow JK, Werner BG, Ruthazer R, Snydman DR. Increased serum iron levels and infectious complications after liver transplantation. Clin Infect Dis 2010; 51(3):e16-e23. PMID: 20578876
Klein A, Miller KB, Sprague K, DesJardin JA, Snydman DR. A randomized, double blind, placebo-controlled trial of valacyclovir prophylaxis to prevent zoster recurrence from months 4 to 24 after BMT. Bone Marrow Transplant 2011;46(2):294-9. PMID: 20421867
Poutsiaka DD, Munson D, Price LL, Chan GW, Snydman DR. Blood stream infection (BSI) and acute GVHD after hematopoietic SCT (HSCT) are associated. Bone Marrow Transplant 2011;46(2):300-7. PMID: 20479711
Su SH, Martel-Laferriere V, Labbe AC, Snydman DR, Kent D, Laverdiere M, Beliveau C, Logvinenko T, Cohen S, Lachance S, Kiss T, Roy J. High incidence of Herpes Zoster in nonmyeloablative hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2011;17:101201017. PMID: 20977944
Snydman DR, Jacobus NV, McDermott LA. In vitro activity of Ceftaroline against a broad spectrum of recent clinical anaerobic isolates. Antimicrob Agents Chemother 2011;55(1):421-425. PMID: 21041506
Snydman DR, Limaye AP, Potena L, Zamora MR. Update and review: state-of-the-art management of cytomegalovirus infection and disease following thoracic organ transplantation. Transplant Proc 2011;43(3 Suppl):S1-S17. PMID: 21482317
Snydman DR, Kistler KD, Ulsh P, Bergman GE, Vensak J, Morris J. The impact of CMV prevention on long-term recipient and graft survival in heart transplant recipients: analysis of the Scientific Registry of Transplant Recipients (SRTR) database. Clin Transplant 2011;e455-e462. PMID: 21504474
Lubin AS, Snydman DR, Ruthazer R, Bide P, Golan Y. Predicting high vancomycin minimum inhibitory concentration in methicillin-resistant Staphylococcus aureus bloodstream infections. Clin Infect Dis 2011:52(8): 997-1002. PMID: 21460313
Davidson LE, Fiorino AM, Snydman DR, Hibberd PL. Lactobacillus GG as an immune adjuvant for live-attenuated influenza vaccine in healthy adults: a randomized double-blind placebo-controlled trial. Eur J Clin Nutr 2011;65(4):501-7. PMID: 21285968
Doron SI, Kifuji K, Hynes BT, Dunlop D, Lemon T, Hansjosten K, Cheung T, Curley B, Snydman DR, Fairchild DG. A multifaceted approach to education, observation, and feedback in successful hand hygiene campaign. Jt Comm J Qual Patient Saf 2011;37(1):3-10. PMID: 21306060
Lubin AS, Snydman DR, Miller KB. Persistent babesiosis in a stem cell transplant recipient. Leuk Res 2011;35(6):e77-8. PMID: 21185598
Snydman DR. Why did maribavir fail in stem-cell transplants? Lancet Infect Dis 2011;11(4):255-7. PMID: 21414844
Snydman DR. Putting the IMPACT study into perspective: should CMV prophylaxis be extended to 6 months for high risk transplants? Am J Transplant 2011;11(1):6-7. PMID: 21199341
Additional Publications
PubMed
|